??-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies, Proceedings of the National Academy of Sciences, vol.95, issue.11, pp.6469-73, 1998. ,
DOI : 10.1073/pnas.95.11.6469
Alpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship, Molecular Neurobiology, vol.69, issue.1, pp.537-51, 2013. ,
DOI : 10.1007/s12035-012-8341-2
Protein degradation pathways in Parkinson???s disease: curse or blessing, Acta Neuropathologica, vol.12, issue.1, pp.153-72, 2012. ,
DOI : 10.1007/s00401-012-1004-6
??-Synuclein Is Degraded by Both Autophagy and the Proteasome, Journal of Biological Chemistry, vol.278, issue.27, pp.25009-25022, 2003. ,
DOI : 10.1074/jbc.M300227200
Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies, Movement Disorders, vol.137, issue.Pt 5, pp.178-92, 2016. ,
DOI : 10.1002/mds.26477
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice, Nature, vol.16, issue.7095, pp.885-894, 2006. ,
DOI : 10.1038/nature04724
Loss of autophagy in the central nervous system causes neurodegeneration in mice, Nature, vol.275, issue.7095, pp.880-884, 2006. ,
DOI : 10.1038/nature04723
The role of autophagy in neurodegenerative disease, Nature Medicine, vol.5, issue.8, pp.983-97, 2013. ,
DOI : 10.1038/nm.3232
The role of autophagy in Parkinson's disease. Cold Spring Harb Perspect Med, 2012. ,
Fighting neurodegeneration with rapamycin: mechanistic insights Autophagy modulation as a potential therapeutic target for diverse diseases, Nat Rev Neurosci. Nat Rev Drug Discov, vol.1211, pp.437-52709, 2011. ,
Microautophagy: lesser-known self-eating, Cellular and Molecular Life Sciences, vol.5, issue.7, pp.1125-1161, 2012. ,
DOI : 10.1007/s00018-011-0865-5
Regulation of Mammalian Autophagy in Physiology and Pathophysiology, Physiological Reviews, vol.90, issue.4, pp.1383-435, 2009. ,
DOI : 10.1152/physrev.00030.2009
Autophagy, Trends Cell Biol, vol.14, pp.70-77, 2004. ,
DOI : 10.1016/B978-0-12-394447-4.30054-2
URL : https://hal.archives-ouvertes.fr/hal-01439629
Autophagy: More Than a Nonselective Pathway, International Journal of Cell Biology, vol.1, issue.1, pp.219625-219635, 2012. ,
DOI : 10.1016/S1097-2765(01)00263-5
URL : http://doi.org/10.1155/2012/219625
Mechanistic insights into selective autophagy pathways: lessons from yeast, Nature Reviews Molecular Cell Biology, vol.335, issue.9, pp.537-52, 2016. ,
DOI : 10.1111/j.1600-0854.2004.00245.x
Ubiquitin-Dependent And Independent Signals In Selective Autophagy, Trends in Cell Biology, vol.26, issue.1, pp.6-16, 2016. ,
DOI : 10.1016/j.tcb.2015.08.010
Mammalian Autophagy: How Does It Work?, Annual Review of Biochemistry, vol.85, issue.1, pp.685-713, 2016. ,
DOI : 10.1146/annurev-biochem-060815-014556
mTOR Signaling in Growth Control and Disease, Cell, vol.149, issue.2, pp.274-93, 2012. ,
DOI : 10.1016/j.cell.2012.03.017
URL : http://doi.org/10.1016/j.cell.2012.03.017
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1, Nature Cell Biology, vol.4, issue.2, pp.132-173, 2011. ,
DOI : 10.1016/j.cub.2010.04.041
Tsc tumour suppressor proteins antagonize amino-acid???TOR signalling, Nature Cell Biology, vol.4, issue.9, pp.699-704, 2002. ,
DOI : 10.1038/ncb847
Beclin 1 Forms Two Distinct Phosphatidylinositol 3-Kinase Complexes with Mammalian Atg14 and UVRAG, Molecular Biology of the Cell, vol.19, issue.12, pp.5360-72, 2008. ,
DOI : 10.1091/mbc.E08-01-0080
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592660
Autophagy in Human Health and Disease, New England Journal of Medicine, vol.368, issue.7, pp.1845-1851, 2013. ,
DOI : 10.1056/NEJMra1205406
Role of AMPK-mTOR-Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and Feedbacks, Molecular and Cellular Biology, vol.32, issue.1, pp.2-11, 2012. ,
DOI : 10.1128/MCB.06159-11
A Gene Network Regulating Lysosomal Biogenesis and Function, Science, vol.325, pp.473-480, 2009. ,
DOI : 10.1126/science.1174447
TFEB Links Autophagy to Lysosomal Biogenesis, Science, vol.332, issue.6036, pp.1429-1462, 2011. ,
DOI : 10.1126/science.1204592
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638014
A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB, The EMBO Journal, vol.12, issue.5, pp.1095-108, 2012. ,
DOI : 10.1038/emboj.2012.32
mTORC1 Senses Lysosomal Amino Acids Through an Inside-Out Mechanism That Requires the Vacuolar H+-ATPase, Science, vol.334, issue.6056, pp.678-83, 2011. ,
DOI : 10.1126/science.1207056
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway, Nature Chemical Biology, vol.4, issue.5, pp.295-305, 2008. ,
DOI : 10.1038/nchembio.79
Regulation of autophagy by the inositol trisphosphate receptor, Cell Death and Differentiation, vol.114, pp.1029-1068, 2007. ,
DOI : 10.1016/j.molcel.2004.09.026
URL : https://hal.archives-ouvertes.fr/hal-00216049
Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease, Autophagy, vol.7, issue.9, 2015. ,
DOI : 10.1016/S0140-6736(14)61010-2
The link between the GBA gene and parkinsonism, The Lancet Neurology, vol.11, issue.11, pp.986-98, 2012. ,
DOI : 10.1016/S1474-4422(12)70190-4
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141416
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease, New England Journal of Medicine, vol.361, issue.17, pp.1651-61, 2009. ,
DOI : 10.1056/NEJMoa0901281
mutation and parkinson's disease, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, vol.91, issue.1, pp.96-102, 2014. ,
DOI : 10.1002/ajmg.b.32214
Mutations in GBA and risk of Parkinson???s disease: a meta-analysis based on 25 case-control studies, Neurological Research, vol.4, issue.8, pp.873-881, 2013. ,
DOI : 10.1038/ng1333
Glucocerebrosidase and Parkinson disease: Recent advances, Molecular and Cellular Neuroscience, vol.66, pp.37-42, 2015. ,
DOI : 10.1016/j.mcn.2015.03.013
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471139
Lysosomal Dysfunction and alpha-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links, Mov Disord, 2016. ,
DOI : 10.1002/mds.26562
LIMP-2 Is a Receptor for Lysosomal Mannose-6-Phosphate-Independent Targeting of ??-Glucocerebrosidase, Cell, vol.131, issue.4, pp.770-83, 2007. ,
DOI : 10.1016/j.cell.2007.10.018
The contribution of Niemann-Pick SMPD1 mutations to Parkinson disease in Ashkenazi Jews, Parkinsonism & Related Disorders, vol.21, issue.9, pp.1067-71, 2015. ,
DOI : 10.1016/j.parkreldis.2015.06.016
Rare lysosomal enzyme gene SMPD1 variant (p. R591C) associates with Parkinson's disease, Neurobiol Aging, vol.34, 2013. ,
DOI : 10.1016/j.neurobiolaging.2013.06.010
The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease, Neurology, vol.80, issue.17, pp.1606-1616, 2013. ,
DOI : 10.1212/WNL.0b013e31828f180e
The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease, Neurology, vol.82, issue.3, 2014. ,
DOI : 10.1212/WNL.0000000000000004
URL : https://hal.archives-ouvertes.fr/in2p3-00023345
Advances in the genetics of Parkinson disease, Nature Reviews Neurology, vol.8, issue.8, pp.445-54, 2013. ,
DOI : 10.1038/nrneurol.2013.132
The Parkinson's disease???linked proteins Fbxo7 and Parkin interact to mediate mitophagy, Nature Neuroscience, vol.4, issue.9, pp.1257-65, 2013. ,
DOI : 10.1038/cdd.2009.23
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827746
Interplay of LRRK2 with chaperone-mediated autophagy, Nature Neuroscience, vol.182, issue.4, pp.394-406, 2013. ,
DOI : 10.1073/pnas.76.9.4350
Interplay between Leucine-Rich Repeat Kinase 2 (LRRK2) and p62/SQSTM-1 in Selective Autophagy, PLOS ONE, vol.6, issue.5, 2016. ,
DOI : 10.1371/journal.pone.0163029.g005
URL : http://doi.org/10.1371/journal.pone.0163029
Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells, Journal of Neurochemistry, vol.13, issue.3 ,
DOI : 10.1016/j.neuron.2004.11.005
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease, Histol Histopathol, vol.12, pp.25-31, 1997. ,
Molecular changes in the postmortem parkinsonian brain, Journal of Neurochemistry, vol.51, issue.1, pp.27-58, 2016. ,
DOI : 10.1111/jnc.13696
Pathogenic Lysosomal Depletion in Parkinson's Disease, Journal of Neuroscience, vol.30, issue.37, pp.12535-12579, 2010. ,
DOI : 10.1523/JNEUROSCI.1920-10.2010
Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease, Neurobiology of Disease, vol.43, issue.3, pp.690-697, 2011. ,
DOI : 10.1016/j.nbd.2011.05.022
Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions, Neurobiology of Disease, vol.35, issue.3, pp.385-98, 2009. ,
DOI : 10.1016/j.nbd.2009.05.023
Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains, Archives of Neurology, vol.67, issue.12, pp.1464-72, 2010. ,
DOI : 10.1001/archneurol.2010.198
Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease, Movement Disorders, vol.9, issue.Suppl 1, pp.1639-1686, 2015. ,
DOI : 10.1002/mds.26141
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains, Annals of Neurology, vol.115, issue.suppl 1, pp.455-63, 2012. ,
DOI : 10.1002/ana.23614
Reduced glucocerebrosidase is associated with increased ??-synuclein in sporadic Parkinson's disease, Brain, vol.137, issue.3, pp.834-882, 2014. ,
DOI : 10.1093/brain/awt367
URL : http://doi.org/10.1093/brain/awt367
Selective loss of glucocerebrosidase activity in sporadic Parkinson???s disease and dementia with Lewy bodies, Molecular Neurodegeneration, vol.3, issue.6, pp.15-25, 2015. ,
DOI : 10.1186/s13024-015-0010-2
Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease, Movement Disorders, vol.349, issue.10, pp.1481-1485, 2007. ,
DOI : 10.1002/mds.21399
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease, Movement Disorders, vol.34, issue.6, pp.747-54, 2013. ,
DOI : 10.1002/mds.25495
Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease, Movement Disorders, vol.69, issue.Pt 3, pp.1019-1046, 2014. ,
DOI : 10.1002/mds.25772
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282452
LIMP-2 expression is critical for ??-glucocerebrosidase activity and ??-synuclein clearance, Proceedings of the National Academy of Sciences, vol.111, issue.43, pp.15573-15581, 2014. ,
DOI : 10.1073/pnas.1405700111
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217458
Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease, Journal of the Neurological Sciences, vol.131, issue.1, pp.65-70, 1995. ,
DOI : 10.1016/0022-510X(95)00035-Z
ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies, Acta Neuropathologica Communications, vol.1, issue.1 ,
DOI : 10.1016/S1474-4422(09)70238-8
PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity, Human Molecular Genetics, vol.21, issue.8, pp.1725-1768, 2012. ,
DOI : 10.1093/hmg/ddr606
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465694
Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson???s Disease, PLOS ONE, vol.135, issue.3, 2015. ,
DOI : 10.1371/journal.pone.0128651.s008
Expression analysis of dopaminergic neurons in Parkinson???s disease and aging links transcriptional dysregulation of energy metabolism to cell death, Acta Neuropathologica, vol.137, issue.Suppl 2, pp.75-86, 2011. ,
DOI : 10.1007/s00401-011-0828-9
Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease, Neurobiology of Disease, vol.63, pp.165-70, 2014. ,
DOI : 10.1016/j.nbd.2013.11.007
Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy, Plos One, vol.5, 2010. ,
Alteration of Upstream Autophagy-Related Proteins (ULK1, ULK2, Beclin1, VPS34 and AMBRA1) in Lewy Body Disease, Brain Pathology, vol.11, issue.3, pp.359-70, 2015. ,
DOI : 10.1111/bpa.12297
TFEB-mediated autophagy rescues midbrain dopamine neurons from ??-synuclein toxicity, Proceedings of the National Academy of Sciences, vol.110, issue.19, pp.1817-1843, 2013. ,
DOI : 10.1073/pnas.1305623110
Wild Type ??-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells, Journal of Biological Chemistry, vol.283, issue.35, pp.23542-56, 2008. ,
DOI : 10.1074/jbc.M801992200
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527094
Metabolic Activity Determines Efficacy of Macroautophagic Clearance of Pathological Oligomeric ??-Synuclein, The American Journal of Pathology, vol.175, issue.2, pp.736-783, 2009. ,
DOI : 10.2353/ajpath.2009.080928
Impaired Degradation of Mutant ??-Synuclein by Chaperone-Mediated Autophagy, Science, vol.305, issue.5688, pp.1292-1297, 2004. ,
DOI : 10.1126/science.1101738
Polo-like kinase 2 regulates selective autophagic ??-synuclein clearance and suppresses its toxicity in vivo, Proceedings of the National Academy of Sciences, vol.110, issue.41, pp.3945-54, 2013. ,
DOI : 10.1073/pnas.1309991110
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799334
Phosphorylation Modulates Clearance of Alpha-Synuclein Inclusions in a Yeast Model of Parkinson's Disease, PLoS Genetics, vol.21, issue.5, 2014. ,
DOI : 10.1371/journal.pgen.1004302.s014
Gaucher Disease Glucocerebrosidase and ??-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies, Cell, vol.146, issue.1, pp.37-52, 2011. ,
DOI : 10.1016/j.cell.2011.06.001
URL : http://doi.org/10.1016/j.cell.2011.06.001
Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: A biological link between Gaucher disease and parkinsonism, NeuroToxicology, vol.30, issue.6, pp.1127-1159, 2009. ,
DOI : 10.1016/j.neuro.2009.06.009
CNS expression of glucocerebrosidase corrects ??-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy, Proceedings of the National Academy of Sciences, vol.108, issue.29, pp.12101-12107, 2011. ,
DOI : 10.1073/pnas.1108197108
Haploinsufficiency of cathepsin D leads to lysosomal dysfunction and promotes cell-to-cell transmission of alpha-synuclein aggregates, Cell Death Dis, vol.6, 2015. ,
Glucocerebrosidase depletion enhances cell-to-cell transmission of ??-synuclein, Nature Communications, vol.113, p.4755, 2014. ,
DOI : 10.1371/journal.pone.0019338
mTOR: on target for novel therapeutic strategies in the nervous system, Trends in Molecular Medicine, vol.19, issue.1, pp.51-60 ,
DOI : 10.1016/j.molmed.2012.11.001
Rapamycin protects against rotenone-induced apoptosis through autophagy induction, Neuroscience, vol.164, issue.2, pp.541-51, 2009. ,
DOI : 10.1016/j.neuroscience.2009.08.014
Rapamycin Protects against Neuron Death in In Vitro andIn Vivo Models of Parkinson's Disease, Journal of Neuroscience, vol.30, issue.3, pp.1166-75, 2010. ,
DOI : 10.1523/JNEUROSCI.3944-09.2010
Rapamycin improves motor function, reduces 4-hydroxynonenal adducted protein in brain, and attenuates synaptic injury in a mouse model of synucleinopathy, Pathobiology of Aging & Age-related Diseases, vol.5, issue.1, 2015. ,
DOI : 10.1002/ana.67
Inhibition of mTOR Signaling in Parkinson's Disease Prevents L-DOPA-Induced Dyskinesia, Science Signaling, vol.2, issue.80 ,
DOI : 10.1126/scisignal.2000308
mTOR inhibition alleviates L-DOPA-induced dyskinesia in parkinsonian rats, J Parkinsons Dis, vol.3, pp.13-20, 2013. ,
Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss, Nature Neuroscience, vol.80, issue.9, pp.1129-1164, 2009. ,
DOI : 10.1038/nn.2372
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745154
Lithium induces autophagy by inhibiting inositol monophosphatase, The Journal of Cell Biology, vol.7, issue.7, pp.1101-1112, 2005. ,
DOI : 10.1093/hmg/11.9.1137
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2171537
Neuroprotective Effects of Lithium: Implications for the Treatment of Alzheimer???s Disease and Related Neurodegenerative Disorders, ACS Chemical Neuroscience, vol.5, issue.6, pp.443-50, 2014. ,
DOI : 10.1021/cn5000309
Potential application of lithium in Parkinson's and other neurodegenerative diseases, Frontiers in Neuroscience, vol.83, issue.209, 2015. ,
DOI : 10.1016/j.brainresbull.2010.07.008
Lithium: A review of pharmacology, clinical uses, and toxicity, European Journal of Pharmacology, vol.740, pp.464-73, 2014. ,
DOI : 10.1016/j.ejphar.2014.06.042
Lithium protects dopaminergic cells from rotenone toxicity via autophagy enhancement, BMC Neuroscience, vol.44, issue.12, 2015. ,
DOI : 10.1186/s12868-015-0222-y
URL : http://doi.org/10.1186/s12868-015-0222-y
Therapeutic Effects of Valproate Combined With Lithium Carbonate on MPTP-Induced Parkinsonism in Mice: Possible Mediation Through Enhanced Autophagy, International Journal of Neuroscience, vol.273, issue.4, pp.73-82, 2013. ,
DOI : 10.1074/jbc.M001475200
AMP Kinase Activation Mitigates Dopaminergic Dysfunction and Mitochondrial Abnormalities in Drosophila Models of Parkinson's Disease, Journal of Neuroscience, vol.32, issue.41, pp.14311-14318, 2012. ,
DOI : 10.1523/JNEUROSCI.0499-12.2012
Neuroprotective effect of metformin in MPTP-induced Parkinson???s disease in mice, Neuroscience, vol.277, issue.277, pp.747-54, 2014. ,
DOI : 10.1016/j.neuroscience.2014.07.046
The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro, Neurobiology of Disease, vol.63, pp.1-11, 2014. ,
DOI : 10.1016/j.nbd.2013.11.002
Metformin lowers Ser-129 phosphorylated alpha-synuclein levels Via mtor-dependent protein phosphatase 2A activation, Cell Death Dis, vol.5, 2014. ,
Resveratrol Protects from Toxin-Induced Parkinsonism: Plethora of Proofs Hitherto Petty Translational Value, Molecular Neurobiology, vol.25, issue.5, pp.2751-60, 2015. ,
DOI : 10.1166/jbn.2015.2107
Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson???s Disease, Neurosignals, vol.19, issue.3, pp.163-74, 2011. ,
DOI : 10.1159/000328516
Resveratrol Partially Prevents Rotenone-Induced Neurotoxicity in Dopaminergic SH-SY5Y Cells through Induction of Heme Oxygenase-1 Dependent Autophagy, International Journal of Molecular Sciences, vol.15, issue.1, pp.1625-1671, 2014. ,
DOI : 10.3390/ijms15011625
Effect of resveratrol on mitochondrial function: Implications in parkin-associated familiar Parkinson's disease, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1842, issue.7, pp.902-917, 2014. ,
DOI : 10.1016/j.bbadis.2014.02.010
Trehalose inhibits solute carrier 2A (SLC2A) proteins to induce autophagy and prevent hepatic steatosis, Sci Signal, vol.9, p.21, 2016. ,
Trehalose, a Novel mTOR-independent Autophagy Enhancer, Accelerates the Clearance of Mutant Huntingtin and ??-Synuclein, Journal of Biological Chemistry, vol.282, issue.8, pp.5641-52, 2007. ,
DOI : 10.1074/jbc.M609532200
The accumulation of neurotoxic proteins, induced by proteasome inhibition, is reverted by trehalose, an enhancer of autophagy, in human neuroblastoma cells, Neurochemistry International, vol.58, issue.4, pp.512-532, 2011. ,
DOI : 10.1016/j.neuint.2011.01.008
Rotenone impairs autophagic flux and lysosomal functions in Parkinson???s disease, Neuroscience, vol.284, pp.900-911, 2015. ,
DOI : 10.1016/j.neuroscience.2014.11.004
Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson's disease mouse model, NeuroToxicology, vol.44, pp.250-62, 2014. ,
DOI : 10.1016/j.neuro.2014.07.006
Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV ??-Synuclein Rat Model of Parkinson???s Disease, Molecular Neurobiology, vol.25, issue.Suppl 3, pp.2258-68, 2015. ,
DOI : 10.1007/s12035-015-9173-7
Trehalose intake induces chaperone molecules along with autophagy in a mouse model of Lewy body disease, Biochemical and Biophysical Research Communications, vol.465, issue.4, pp.746-52, 2015. ,
DOI : 10.1016/j.bbrc.2015.08.076
The potential of lactulose and melibiose, two novel trehalase-indigestible and autophagy-inducing disaccharides, for polyQ-mediated neurodegenerative disease treatment, NeuroToxicology, vol.48, pp.120-150, 2015. ,
DOI : 10.1016/j.neuro.2015.03.009
Small molecules enhance autophagy and reduce toxicity in Huntington's disease models, Nature Chemical Biology, vol.36, issue.6, pp.331-339, 2007. ,
DOI : 10.1534/genetics.104.026658
Small molecule enhancers of autophagy for neurodegenerative diseases, Molecular BioSystems, vol.132, issue.Suppl, pp.895-901, 2008. ,
DOI : 10.1039/b804606a
Latrepirdine (dimebon) enhances autophagy and reduces intracellular GFP-Abeta42 levels in yeast, J Alzheimers Dis, vol.32, pp.949-67, 2012. ,
Latrepirdine stimulates autophagy and reduces accumulation of ??-synuclein in cells and in mouse brain, Molecular Psychiatry, vol.390, issue.8, pp.882-890, 2013. ,
DOI : 10.1083/jcb.200606084
Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer???s and other neurodegenerative diseases, Translational Psychiatry, vol.24, issue.12, 2013. ,
DOI : 10.1111/j.1742-4658.2009.07346.x
URL : http://doi.org/10.1038/tp.2013.97
Therapeutic prospects for Parkinson disease, Annals of Neurology, vol.27, issue.suppl 3 ,
DOI : 10.1002/ana.24011
Spermidine protects against ??-synuclein neurotoxicity, Cell Cycle, vol.77, issue.24, pp.3903-3911, 2014. ,
DOI : 10.1371/journal.pgen.1003664
Curcumin Ameliorates the Neurodegenerative Pathology in A53T ??-synuclein Cell Model of Parkinson???s Disease Through the Downregulation of mTOR/p70S6K Signaling and the Recovery of Macroautophagy, Journal of Neuroimmune Pharmacology, vol.103, issue.8, pp.356-69, 2013. ,
DOI : 10.1007/s11481-012-9431-7
Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson's disease, Neurobiology of Aging, vol.33, issue.4, pp.767-85, 2012. ,
DOI : 10.1016/j.neurobiolaging.2010.05.021
(Poly)phenols protect from ??-synuclein toxicity by reducing oxidative stress and promoting autophagy, Human Molecular Genetics, vol.24, issue.6, pp.1717-1749, 2015. ,
DOI : 10.1093/hmg/ddu585
Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of ??-synuclein in Parkinson's disease models, Human Molecular Genetics, vol.22, issue.16, pp.3315-3343, 2013. ,
DOI : 10.1093/hmg/ddt192
c-Abl phosphorylates ??-synuclein and regulates its degradation: implication for ??-synuclein clearance and contribution to the pathogenesis of Parkinson's disease, Human Molecular Genetics, vol.23, issue.11, pp.2858-79, 2014. ,
DOI : 10.1093/hmg/ddt674
Life in the balance ??? a mechanistic view of the crosstalk between autophagy and apoptosis, Journal of Cell Science, vol.125, issue.22, pp.5259-68, 2012. ,
DOI : 10.1242/jcs.115865
Recent insights into the function of autophagy in cancer: Table 1., Genes & Development, vol.30, issue.17, 2016. ,
DOI : 10.1101/gad.287524.116
Deconvoluting the context-dependent role for autophagy in cancer, Nature Reviews Cancer, vol.108, issue.6, pp.401-411, 2012. ,
DOI : 10.1038/nrc3262
Dopamine induces autophagic cell death and ??-synuclein increase in human neuroblastoma SH-SY5Y cells, Journal of Neuroscience Research, vol.170, issue.3, pp.341-50, 2003. ,
DOI : 10.1002/jnr.10663
Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death, J Neurosci, vol.21, pp.9549-60, 2001. ,
A novel mTOR activating protein protects dopamine neurons against oxidative stress by repressing autophagy related cell death, Journal of Neurochemistry, vol.170, issue.Suppl 6, pp.366-76, 2009. ,
DOI : 10.1111/j.1471-4159.2009.06463.x
Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease, Cellular Signalling, vol.26, issue.8, pp.1680-1689, 2014. ,
DOI : 10.1016/j.cellsig.2014.04.009
Akt Suppresses Retrograde Degeneration of Dopaminergic Axons by Inhibition of Macroautophagy, Journal of Neuroscience, vol.31, issue.6, pp.2125-2160, 2011. ,
DOI : 10.1523/JNEUROSCI.5519-10.2011
Induction of autophagy in neurite degeneration of mouse superior cervical ganglion neurons, European Journal of Neuroscience, vol.13, issue.10, pp.2979-88, 2007. ,
DOI : 10.1111/j.1460-9568.2007.05914.x
Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy, Plos One, vol.4, 2009. ,
Mutant A53T ??-Synuclein Induces Neuronal Death by Increasing Mitochondrial Autophagy, Journal of Biological Chemistry, vol.286, issue.12, pp.10814-10838, 2011. ,
DOI : 10.1074/jbc.M110.132514
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060532
Autosis and autophagic cell death: the dark side of autophagy, Cell Death and Differentiation, vol.38, issue.3, pp.367-76, 2015. ,
DOI : 10.4161/auto.28784
Autophagic activity in neuronal cell death, Neuroscience Bulletin, vol.6, issue.4, pp.382-94, 2015. ,
DOI : 10.1007/s12264-015-1528-y
Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in ??-Synuclein Models of Parkinson's and Lewy Body Diseases, Journal of Neuroscience, vol.29, issue.43, pp.13578-88, 2009. ,
DOI : 10.1523/JNEUROSCI.4390-09.2009
Beclin1 and HMGB1 ameliorate the ??-synuclein-mediated autophagy inhibition in PC12 cells, Diagnostic Pathology, vol.26, issue.2, pp.15-25, 2016. ,
DOI : 10.1186/s13000-016-0459-5
Protective effect of tamoxifen on 1-methyl-4-phenylpyridine-induced hydroxyl radical generation in the rat striatum, Neuroscience Letters, vol.308, issue.2, pp.87-90, 2001. ,
DOI : 10.1016/S0304-3940(01)01966-8
The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse, Neurobiology of Disease, vol.68, pp.1-15, 2014. ,
DOI : 10.1016/j.nbd.2014.04.003
Isorhynchophylline, a natural alkaloid, promotes the degradation of alpha-synuclein in neuronal cells via inducing autophagy, Autophagy, vol.8, issue.1, pp.98-108, 2012. ,
DOI : 10.4161/auto.8.1.18313
2-Hydroxypropyl-??-cyclodextrin Promotes Transcription Factor EB-mediated Activation of Autophagy: IMPLICATIONS FOR THERAPY, Journal of Biological Chemistry, vol.289, issue.14, pp.10211-10233, 2014. ,
DOI : 10.1074/jbc.M113.506246
Genetic and chemical activation of TFEB mediates clearance of aggregated alpha-synuclein, Plos One, vol.10, 2015. ,
Acidic Nanoparticles Are Trafficked to Lysosomes and Restore an Acidic Lysosomal pH and Degradative Function to Compromised ARPE-19 Cells, PLoS ONE, vol.4, issue.12, 2012. ,
DOI : 10.1371/journal.pone.0049635.s003
URL : http://doi.org/10.1371/journal.pone.0049635
Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases, Autophagy, vol.269, issue.3, pp.472-83, 2016. ,
DOI : 10.1016/j.nbd.2013.09.020
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835967
Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies, Proceedings of the National Academy of Sciences, vol.110, issue.9, pp.3537-3579, 2013. ,
DOI : 10.1073/pnas.1220464110
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587272
Glucocerebrosidase gene therapy prevents ??-synucleinopathy of midbrain dopamine neurons, Neurobiology of Disease, vol.82, pp.495-503, 2015. ,
DOI : 10.1016/j.nbd.2015.09.009
URL : http://doi.org/10.1016/j.nbd.2015.09.009
Glucocerebrosidase in the pathogenesis and treatment of Parkinson disease: Fig. 1., Proceedings of the National Academy of Sciences, vol.110, issue.9, pp.3214-3219, 2013. ,
DOI : 10.1073/pnas.1300822110
Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance, Journal of Neurochemistry, vol.2, issue.37, 2016. ,
DOI : 10.1111/jnc.13517
Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells, Brain, vol.137, issue.5, pp.1481-95, 2014. ,
DOI : 10.1093/brain/awu020
Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells, Neurobiology of Disease, vol.82, pp.235-277, 2015. ,
DOI : 10.1016/j.nbd.2015.06.008
Glucocerebrosidase is shaking up the synucleinopathies, Brain, vol.137, issue.5, pp.1304-1326, 2014. ,
DOI : 10.1093/brain/awu002
Ambroxol: A CNS Drug?, CNS Neuroscience & Therapeutics, vol.21, issue.1, pp.17-24, 2008. ,
DOI : 10.1016/j.tins.2006.07.006
The chaperone activity and toxicity of ambroxol on Gaucher cells and normal mice, Brain and Development, vol.35, issue.4, pp.317-339, 2013. ,
DOI : 10.1016/j.braindev.2012.05.008
The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of ??-glucosidase, FEBS Journal, vol.93, issue.7, pp.1618-1656, 2010. ,
DOI : 10.1111/j.1742-4658.2010.07588.x
The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms, Proceedings of the National Academy of Sciences, vol.103, issue.37, pp.13813-13821, 2006. ,
DOI : 10.1073/pnas.0605928103
Ex Vivo and in Vivo Effects of Isofagomine on Acid ??-Glucosidase Variants and Substrate Levels in Gaucher Disease, Journal of Biological Chemistry, vol.287, issue.6, pp.4275-87, 2012. ,
DOI : 10.1074/jbc.M111.280016
Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones, Proceedings of the National Academy of Sciences, vol.110, issue.3, pp.966-71, 2013. ,
DOI : 10.1073/pnas.1221046110
A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy, Neurotherapeutics, vol.118, issue.4, pp.840-56, 2014. ,
DOI : 10.1007/s13311-014-0294-x
Discovery, Structure???Activity Relationship, and Biological Evaluation of Noninhibitory Small Molecule Chaperones of Glucocerebrosidase, Journal of Medicinal Chemistry, vol.55, issue.12, pp.5734-5782, 2012. ,
DOI : 10.1021/jm300063b
Macrophage Models of Gaucher Disease for Evaluating Disease Pathogenesis and Candidate Drugs, Science Translational Medicine, vol.6, issue.240, pp.240-73, 2014. ,
DOI : 10.1126/scitranslmed.3008659
A New Glucocerebrosidase Chaperone Reduces ??-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism, Journal of Neuroscience, vol.36, issue.28, pp.7441-52, 2016. ,
DOI : 10.1523/JNEUROSCI.0636-16.2016
Boosting chaperone-mediated autophagy in vivo mitigates ??-synuclein-induced neurodegeneration, Brain, vol.136, issue.7, pp.2130-2176, 2013. ,
DOI : 10.1093/brain/awt131
URL : http://doi.org/10.1093/brain/awt131
Chemical modulation of chaperone-mediated autophagy by retinoic acid derivatives, Nature Chemical Biology, vol.124, issue.6, pp.374-82, 2013. ,
DOI : 10.1038/nchembio.1230
Mitophagy and the therapeutic clearance of damaged mitochondria for neuroprotection, The International Journal of Biochemistry & Cell Biology, vol.79, pp.382-389, 2016. ,
DOI : 10.1016/j.biocel.2016.08.019
PMI: A ????m Independent Pharmacological Regulator of Mitophagy, Chemistry & Biology, vol.21, issue.11, pp.1585-96, 2014. ,
DOI : 10.1016/j.chembiol.2014.09.019
URL : https://hal.archives-ouvertes.fr/hal-01362710
Systems biology of the autophagy-lysosomal pathway, Autophagy, vol.16, issue.5, pp.477-89, 2011. ,
DOI : 10.1016/j.cell.2004.12.035
Downregulation of miR-124 in MPTP-treated mouse model of Parkinson???s disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins, Neuroscience, vol.272, pp.167-79, 2014. ,
DOI : 10.1016/j.neuroscience.2014.04.039
MiR-124 Regulates Apoptosis and Autophagy Process in MPTP Model of Parkinson's Disease by Targeting to Bim, Brain Pathology, vol.27, issue.Pt 11, pp.167-76, 2016. ,
DOI : 10.1111/bpa.12267
Influence of microrna deregulation on chaperone-mediated autophagy and alpha-synuclein pathology in Parkinson's disease, Cell Death Dis, vol.4, 2013. ,
Crosstalk Between Macroautophagy and Chaperone-Mediated Autophagy: Implications for the Treatment of Neurological Diseases, Molecular Neurobiology, vol.32, issue.49, pp.1284-96, 2014. ,
DOI : 10.1523/JNEUROSCI.3049-12.2012
Lewy Body-like ??-Synuclein Aggregates Resist Degradation and Impair Macroautophagy, Journal of Biological Chemistry, vol.288, issue.21, pp.15194-210, 2013. ,
DOI : 10.1074/jbc.M113.457408
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663539